Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check6 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check13 days agoChange DetectedThe record history adds a newer update documenting a change to the study status, following the version submitted on 2026-09-30. This reflects a meaningful update to the trial’s operational status.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record history gains a new revision entry dated 2026-09-14 with Revision: v3.7.0. A related 2026-09-10 entry for Study Status appears, reflecting a maintenance update to the record.SummaryDifference0.4%

- Check56 days agoChange DetectedA new revision entry (v3.6.6) was added and the previous one (v3.6.5) removed in the record history, indicating a platform update to the page rather than a change to the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry v3.6.5 appears in the study's revision history. The previous entry v3.6.4 is removed from the updated history.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry v3.6.4 is added to the history. The previous v3.6.3 entry is removed, reflecting an update to the record's documentation.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.